Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study

• Main Authors: Ohoud Aljuhani (Author), Khalid Al Sulaiman (Author), Ghazwa B. Korayem (Author), Ali F. Altebainawi (Author), Abdulrahman Alshaya (Author), Majed Nahari (Author), Khuzama Alsamnan (Author), Munirah A. Alkathiri (Author), Bodoor S. Al-Dosari (Author), Abeer A. Alenazi (Author), Samiah Alsohimi (Author), Lina I. Alnajjar (Author), Mashael Alfaifi (Author), Nora AlQussair (Author), Reem M. Alanazi (Author), Munirah F. Alhmoud (Author), Nadin L. Alanazi (Author), Hadeel Alkofide (Author), Aljawharah M. Alenezi (Author), Ramesh Vishwakarma (Author)
• Format: Book
• Published: Elsevier, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Backgrounds: Ketamine possesses analgesia, anti-inflammation, anticonvulsant, and neuroprotection properties. However, the evidence that supports its use in mechanically ventilated critically ill patients with COVID-19 is insufficient. The study's goal was to assess ketamine's effectivenes...